Benign Masseteric Hypertrophy Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Phase Ⅱ Optimal Dose-finding Study to Determine the Safety and Efficacy of DWP450 in Subjects With Benign Masseteric Hypertrophy
This study is A Randomized, Double-blind, Placebo-controlled, Phase II Optimal Dose-finding Study to Determine the Safety and Efficacy of DWP450 in Subjects with Benign Masseteric Hypertrophy
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04443244 -
Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy
|
Phase 2 | |
Completed |
NCT04294251 -
Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
|
Phase 3 | |
Recruiting |
NCT05964257 -
To Evaluate the Efficacy and Safety of LIZTOX in Subjects With Benign Masseteric Hypertrophy
|
Phase 3 |